Close this search box.

The Metabolic Flexibility of Cancer Cells

Cancer’s ability to rewire its metabolic pathways is akin to a thief changing disguises. Traditionally, scientists have focused on how cancer cells voraciously consume sugar — a process known as aerobic glycolysis or the Warburg effect. However, recent insights have unveiled a more complex metabolic landscape where fatty acid oxidation (FAO) plays a crucial, albeit previously underestimated, role.

FAO: Beyond Just Energy Production

Fatty acid oxidation isn’t just about energy. It’s a multifaceted process that provides cancer cells with ATP, the energy currency of the cell, and NADPH, a molecule crucial for combating oxidative stress and synthesizing fatty acids. This dual role makes FAO a critical contributor to cancer cell survival, growth, and proliferation.

The Paradox of Fatty Acid Oxidation

While FAO fuels cancer growth, it also interacts intricately with the tumor microenvironment. It’s involved in reprogramming immune cells to create a more suppressive, cancer-friendly environment. This paradoxical role makes understanding and targeting FAO complex but also offers multiple angles for therapeutic intervention.

The Lipolytic Phenotype of Cancer

Many cancers develop a “lipolytic phenotype,” wherein they break down fats aggressively. This isn’t just about feeding their own growth; it’s also about remodeling the surrounding tissues. Cancer cells can induce fat breakdown in nearby cells, essentially co-opting the body’s resources for their own use.

Challenges in Targeting FAO

Targeting FAO for cancer treatment is not without challenges. The pathway is deeply embedded in normal physiology, playing critical roles in the heart, liver, and muscle. This means that inhibitors must be finely tuned to avoid broad metabolic disruptions. Additionally, cancer cells are notorious for their ability to adapt and find workaround pathways when one is blocked.

Emerging Therapies: The New Frontier

Despite the challenges, the potential of targeting FAO in cancer therapy is immense. Early-stage drugs aimed at key enzymes in the FAO pathway are showing promise in preclinical studies. These inhibitors could potentially cut off a vital lifeline for tumors, particularly those resistant to other treatments.

The Broader Context of Cancer Metabolism

Cancer’s metabolic reprogramming extends beyond just FAO and glycolysis. The disease also impacts other pathways like glutaminolysis and lipid synthesis, creating a complex metabolic web. Understanding how FAO interacts with these other pathways is crucial for developing comprehensive treatment strategies.

FAO and the Immune System: A Double-Edged Sword

FAO’s role in modulating the immune system is a double-edged sword. On one hand, it helps cancer evade immune detection. On the other, it offers a backdoor to potentially enhance immune responses against the tumor. Modulating FAO could help ‘re-educate’ immune cells to recognize and attack cancer cells more effectively.

FAO in the Tumor Microenvironment

The tumor microenvironment is a complex ecosystem of cancer cells, immune cells, and stromal cells. FAO plays a role in this interplay, influencing not just the cancer cells but also the surrounding tissues. Targeting FAO could disrupt these interactions, potentially stalling tumor growth and metastasis.

Personalized Medicine and FAO

Not all cancers rely on FAO to the same extent. This variability offers an opportunity for personalized medicine. By understanding a tumor’s specific metabolic profile, treatments can be tailored to target its particular weaknesses, including its dependence on FAO.


The revelation of fatty acid oxidation’s role in cancer has opened a new chapter in our understanding of the disease. It’s a tale of metabolic flexibility, intricate interplays with the microenvironment, and the promise of new avenues for treatment. As our knowledge deepens, so does our potential to craft more effective, targeted therapies that could one day turn the tide against this formidable disease. In this journey, every step forward in understanding FAO’s role not only illuminates the dark corners of cancer’s metabolism but also lights the way for future breakthroughs in treatment.


Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X.-Y., & Fang, X. (2018). Fatty acid oxidation: An emerging facet of metabolic transformation in cancer. Cancer Letters, 435, 92–100. https://doi.org/10.1016/j.canlet.2018.08.006

Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese Jr, R. V. (2013). Cellular fatty acid metabolism and cancer. Cell Metabolism, 18(2), 153–161. https://doi.org/10.1016/j.cmet.2013.05.017